tiprankstipranks
Cautious Optimism for Recursion Pharmaceuticals Amid Promising REC-994 Data and Awaited Pipeline Updates
PremiumRatingsCautious Optimism for Recursion Pharmaceuticals Amid Promising REC-994 Data and Awaited Pipeline Updates
14d ago
Promising Phase II Results for Recursion Pharmaceuticals’ REC-994 Bolster Buy Rating
Premium
Ratings
Promising Phase II Results for Recursion Pharmaceuticals’ REC-994 Bolster Buy Rating
15d ago
Recursion Pharmaceuticals call volume above normal and directionally bullish
Premium
The Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
22d ago
Moderna (MRNA) Surges after Oracle’s Larry Ellison Praises AI-Driven Cancer Vaccines
PremiumMarket NewsModerna (MRNA) Surges after Oracle’s Larry Ellison Praises AI-Driven Cancer Vaccines
1M ago
Recursion Pharmaceuticals call volume above normal and directionally bullish
Premium
The Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
1M ago
Unusually active option classes on open January 22nd
Premium
The Fly
Unusually active option classes on open January 22nd
1M ago
Recursion announces two oncology drugs advancing to clinical trials
PremiumThe FlyRecursion announces two oncology drugs advancing to clinical trials
2M ago
Recursion Pharmaceuticals price target lowered to $10 from $12 at BofA
Premium
The Fly
Recursion Pharmaceuticals price target lowered to $10 from $12 at BofA
2M ago
Recursion Pharmaceuticals CFO Ben Taylor to Join Exscientia
Premium
Company Announcements
Recursion Pharmaceuticals CFO Ben Taylor to Join Exscientia
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100